BRCA1 and ovarian carcinoma: Previously, we reported a high prevalence of BRCA1/2 pathogenic variants (168/718; 23.4%), including 23 BRCA1 founder mutations in high-risk breast and/or ovarian cancer patients from Pakistan [16–18].